Prevnar 20 Vaccination Frequency
For adults ≥18 years: Prevnar 20 is administered as a single dose only—no booster or repeat doses are needed. 1
Adults (≥18 Years of Age)
Prevnar 20 requires only ONE dose for lifetime protection in adults. The FDA-approved dosing schedule is straightforward: a single 0.5 mL intramuscular injection completes the vaccination series 1. This applies whether you're vaccine-naïve or have received prior pneumococcal vaccines.
Timing Based on Prior Vaccination History
The 2024 ACIP guidelines provide specific intervals when transitioning from other pneumococcal vaccines 2:
If previously unvaccinated or only received PCV7:
- Give one dose of PCV20 (or PCV21/PCV15 alternatives)
- No additional doses needed if PCV20 is chosen
If previously received PPSV23 only:
- Wait ≥1 year after last PPSV23 dose
- Then give single dose of PCV20
- Series complete—no further doses
If previously received PCV13 only:
- Wait ≥1 year after PCV13 dose
- Then give single dose of PCV20
- Series complete—no further doses
If received both PCV13 and PPSV23:
- For those <65 years when vaccinated: Wait ≥5 years after last pneumococcal vaccine, then single PCV20 dose
- For those who completed series at ≥65 years: Shared clinical decision-making may support single PCV20 dose ≥5 years after last vaccine 2
Key Point About "One and Done"
Once PCV20 is administered, the pneumococcal vaccination series is complete and no additional pneumococcal vaccine doses are needed 2. This represents a significant simplification over prior multi-dose regimens with PCV13/PPSV23 combinations.
Children and Adolescents (6 Weeks Through 17 Years)
Infants (6 Weeks Through 15 Months)
Standard 4-dose series: Administer at 2,4,6, and 12-15 months of age 1
- First dose can be given as early as 6 weeks
- Fourth dose must be ≥2 months after third dose
- This is the routine immunization schedule
Catch-Up Schedules for Unvaccinated Children
Ages 7-11 months: 3 doses total 1
- First 2 doses ≥4 weeks apart
- Third dose after first birthday, ≥2 months after second dose
Ages 12-23 months: 2 doses total
- Doses ≥2 months apart
Ages ≥24 months through 17 years: Single dose 1
Previously Vaccinated with Lower-Valency PCV
For children 15 months through 17 years who received prior PCV13 or PCV15:
- Give single dose of PCV20
- Wait ≥8 weeks after last lower-valency PCV dose 1
- This completes the series
Important Clinical Considerations
No Routine Boosters
Unlike some vaccines, Prevnar 20 does not require routine booster doses in any age group once the age-appropriate series is completed. The single adult dose or completed pediatric series provides durable protection 1.
Immunocompromised Patients
For adults 19-64 years with immunocompromising conditions, CSF leaks, or cochlear implants, the same single-dose principle applies, though timing intervals may be shortened to 8 weeks (rather than 1 year) when transitioning from certain vaccines 2. However, still only one dose of PCV20 is needed to complete the series.
Common Pitfall to Avoid
Do not confuse the complex multi-dose PPSV23 schedules of the past with PCV20. Prior recommendations involving PCV13 followed by PPSV23 required 2-3 doses with complicated timing. PCV20 eliminates this complexity—one dose completes protection against all 20 serotypes 2, 3.
Recent Guideline Updates
As of October 2024, ACIP lowered the age recommendation from ≥65 years to ≥50 years for all adults 4. This expanded recommendation maintains the single-dose schedule but broadens the eligible population.